EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathophysiology of Cav1.3 L-type calcium channels in the heart

Sahil Zaveri, Ujala Srivastava, Yongxia Sarah Qu, Mohamed Chahine, Mohamed Boutjdir

Frontiers in Physiology · 21.03.2023 · 14

DOI: 10.3389/fphys.2023.1144069 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 21.03.2023. Verfasst von Sahil Zaveri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY, United States. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ca 2+ plays a crucial role in excitation-contraction coupling in cardiac myocytes. Dysfunctional Ca 2+ regulation alters the force of contraction and causes cardiac arrhythmias. Ca 2+ entry into cardiomyocytes is mediated mainly through L-type Ca 2+ channels, leading to the subsequent Ca 2+ release from the sarcoplasmic reticulum. L-type Ca 2+ channels are composed of the conventional Ca v 1.2, ubiquitously expressed in all heart chambers, and the developmentally regulated Ca v 1.3, exclusively expressed in the atria, sinoatrial node, and atrioventricular node in the adult heart. As such, Ca v 1.3 is implicated in the pathogenesis of sinoatrial and atrioventricular node dysfunction as well as atrial fibrillation. More recently, Ca v 1.3 de novo expression was suggested in heart failure. Here, we review the functional role, expression levels, and regulation of Ca v 1.3 in the heart, including in the context of cardiac diseases. We believe that the elucidation of the functional and molecular pathways regulating Ca v 1.3 in the heart will assist in developing novel targeted therapeutic interventions for the aforementioned arrhythmias.

Schlagwörter

Stichwörter der Autor:innen

atrial fibrillationcalcium channelheart failureprotein kinase regulationsinoatrial node dysfunction

Autor:innen und Institutionen

  • Cardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY, United States.
  • Department of Medicine, Cell Biology and Pharmacology, State University of New York Downstate Health Sciences University, Brooklyn, New York, NY, United States.
  • Department of Cardiology, New York Presbyterian Brooklyn Methodist Hospital, New York, NY, United States.
  • CERVO Brain Research Center, Institut Universitaire en Santé Mentale de Québec, Québec, QC, Canada.
  • Department of Medicine, Faculté de Médecine, Université Laval, Quebec, QC, Canada.
  • Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, United States.

Förderung

  • BLRD VA
  • NHLBI NIH HHS

Zitieren

APA

Zaveri, S., Srivastava, U., Qu, Y. S., Chahine, M., & Boutjdir, M. (2023). Pathophysiology of Cav1.3 L-type calcium channels in the heart. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1144069

Vancouver

Zaveri S, Srivastava U, Qu YS, Chahine M, Boutjdir M. Pathophysiology of Cav1.3 L-type calcium channels in the heart. Frontiers in Physiology. 2023;14. doi:10.3389/fphys.2023.1144069

BibTeX
@article{Zaveri2023,
  author = {Zaveri, Sahil and Srivastava, Ujala and Qu, Yongxia Sarah and Chahine, Mohamed and Boutjdir, Mohamed},
  title = {Pathophysiology of Cav1.3 L-type calcium channels in the heart},
  journal = {Frontiers in Physiology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphys.2023.1144069}
}
Kostenlos starten →